Literature DB >> 13230925

Planned care for patients with bronchiectasis.

S M FARBER, M A BENIOFF, J D SMITH.   

Abstract

Bronchiectasis, for which once only the most elementary palliation could be offered, now often can be cured by operation or well controlled by conservative therapy. Since true bronchiectasis implies irreversible anatomic changes, operation offers the only hope of cure, and it should be undertaken whenever it is not contraindicated by extent of involvement, age of the patient or other factors. Surgical results are excellent and mortality is at a minimum. When operation is prohibited, good results can still be anticipated by conservative measures. Such conservative therapy should combine prolonged use of antimicrobial drugs with adequate drainage of the diseased segments and general supportive measures. Any residual infection can be controlled by moderate use of appropriate antimicrobial agents. It is emphasized, however, that the control of bronchiectasis requires very careful diagnostic studies and a detailed analysis of the patient's condition, and that the therapy itself must be carefully adjusted in terms of the individual situation.

Entities:  

Keywords:  BRONCHIECTASIS/therapy

Mesh:

Substances:

Year:  1955        PMID: 13230925      PMCID: PMC1532464     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  5 in total

1.  Enzymatic débridement; particular reference to trypsin and desoxyribonuclease in the control of cough and sputum associated with tuberculosis.

Authors:  S M FARBER; R D GORMAN; D A WOOD; O F GRIMES; S L PHARR
Journal:  J Thorac Surg       Date:  1954-01

2.  Intermittent positive pressure breathing in emphysema of chronic lung diseases.

Authors:  R H SMART; C K DAVENPORT; G W PEARSON
Journal:  J Am Med Assoc       Date:  1952-12-06

3.  The surgical management of bronchiectasis.

Authors:  C F STOREY; E G LAFORET
Journal:  U S Armed Forces Med J       Date:  1953-04

4.  Trypsin inhalations in respiratory conditions with thick sputum.

Authors:  L UNGER; A H UNGER
Journal:  J Am Med Assoc       Date:  1953-07-18

5.  Mechanical production of expiratory flow rates surpassing the capacity of human coughing.

Authors:  A L BARACH; G J BECK
Journal:  Am J Med Sci       Date:  1953-09       Impact factor: 2.378

  5 in total
  1 in total

1.  Mucolytic Effectiveness of Tyloxapol in Chronic Obstructive Pulmonary Disease - A Double-Blind, Randomized Controlled Trial.

Authors:  Martin Koppitz; Charlotte Eschenburg; Emilia Salzmann; Martin Rosewich; Ralf Schubert; Stefan Zielen
Journal:  PLoS One       Date:  2016-06-16       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.